Phibro Animal Health Corporation
PAHC
$43.37
$1.313.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.63% | 32.14% | 23.73% | 12.57% | 7.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.63% | 32.14% | 23.73% | 12.57% | 7.10% |
| Cost of Revenue | 45.23% | 29.63% | 20.31% | 8.14% | 4.28% |
| Gross Profit | 24.55% | 37.92% | 31.14% | 23.28% | 13.67% |
| SG&A Expenses | 12.54% | 18.55% | 17.14% | -8.88% | 137.56% |
| Depreciation & Amortization | -20.46% | -- | -- | -- | -1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.52% | 26.91% | 19.50% | 3.12% | 7.87% |
| Operating Income | 60.89% | 94.44% | 71.80% | 3,009.50% | -0.35% |
| Income Before Tax | 272.14% | 129.75% | 35.71% | 180.31% | -70.11% |
| Income Tax Expenses | 17.10% | 95.00% | -27.85% | 166.73% | -43.12% |
| Earnings from Continuing Operations | 2,190.43% | 148.42% | 150.00% | 187.02% | -93.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,190.43% | 148.42% | 150.00% | 187.02% | -93.46% |
| EBIT | 60.89% | 94.44% | 71.80% | 3,009.50% | -0.35% |
| EBITDA | 56.11% | 76.63% | 58.98% | 269.88% | 1.82% |
| EPS Basic | 2,186.56% | 148.34% | 149.52% | 187.01% | -93.45% |
| Normalized Basic EPS | 141.79% | 167.57% | 73.76% | 208.93% | -45.54% |
| EPS Diluted | 2,186.56% | 145.78% | 162.00% | 185.00% | -93.45% |
| Normalized Diluted EPS | 141.24% | 166.44% | 72.87% | 208.71% | -45.69% |
| Average Basic Shares Outstanding | 0.00% | 0.04% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.25% | 0.47% | 0.52% | 0.19% | 0.25% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.96% | -0.60% | -0.60% | 2.15% | 14.29% |